KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

USA Compression Partners (USAC) Interest Expenses (2016 - 2026)

USA Compression Partners has reported Interest Expenses over the past 14 years, most recently at $45.3 million for Q4 2025.

  • Quarterly Interest Expenses fell 6.82% to $45.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $187.4 million through Dec 2025, down 3.13% year-over-year, with the annual reading at $187.4 million for FY2025, 3.13% down from the prior year.
  • Interest Expenses was $45.3 million for Q4 2025 at USA Compression Partners, down from $47.1 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $49.4 million in Q3 2024 and troughed at $31.8 million in Q1 2022.
  • The 5-year median for Interest Expenses is $42.7 million (2023), against an average of $40.9 million.
  • Year-over-year, Interest Expenses increased 27.1% in 2023 and then dropped 6.82% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $33.0 million in 2021, then grew by 15.24% to $38.0 million in 2022, then grew by 18.01% to $44.8 million in 2023, then grew by 8.44% to $48.6 million in 2024, then decreased by 6.82% to $45.3 million in 2025.
  • Per Business Quant, the three most recent readings for USAC's Interest Expenses are $45.3 million (Q4 2025), $47.1 million (Q3 2025), and $47.7 million (Q2 2025).